October 30 , 2024

AI-Accelerated Breakthroughs: Reshaping the Future of Life Sciences

Wednesday, October 30, 2024 11:00 am / 12:00 pm

Zoom

AI-Accelerated Breakthroughs: Reshaping the Future of Life Sciences

Michelle Wu, Cofounder & CEO, NyquistAI and Josh Li, Principal, R&D Innovation, Acquis Consulting Group, will discuss the revolutionary impact of artificial intelligence across the R&D, medical, and commercial lifecycle in the biopharma industry.

This session will explore how AI is already creating outsized efficiency gains in life sciences and what the immediate and long-term future hold. It will focus on highly differentiated applications unique to the field.

Discover how your organization can leverage cutting-edge AI applications to stay ahead in an increasingly competitive and complex industry landscape.
The current state of the AI ecosystem in Life Sciences
Why the Life Science industry is uniquely positioned to benefit from differentiated AI use cases
How biotech/biopharma can optimize their strategic AI roadmaps to maximize ROI
Detailed use cases of life science-specific AI in clinical, regulatory, and commercial functions

Acquis and Nyquist events are designed to provide actionable insights to bring back to your life science organization.

See the event recording

How Acquis and NyquistAI Enhance Data and AI Service Offerings

Insight generation and data consolidation prove to be stumbling blocks for many life sciences organizations. Acquis’ strategic development offerings, powered by NyquistAI’s platform, leverage internal and external data insights to inform strategy, identify repeating queries, and templatize functions.

Learn more about this partnership

Featured content

See all

Case Study

October 2023

Enabling Growth Through Operating Model Transformation

Strung together from multiple acquisitions, a data science and technology company had a complex organizational structure that was hindering growth. Executives turned to Acquis to design a new operating model that would position the business to realize priority opportunities and pursue sustainable growth.

Insight

May 2024

Quantitative Operating Model Design for Life Sciences Organizations in the Era of AI

In recent years, the Life Sciences industry has witnessed a significant transformation due to the convergence of digital innovation and artificial intelligence (AI). The Life Science companies that are best at deploying AI and machine learning to expedite drug discovery, personalize medicine, and make patient-centric decisions will come out significantly ahead over those that do not.

Insight

August 2020

Opportunities to Pursue a Cost and Differentiation Strategy in Life Sciences Organizations

Artificial intelligence (AI) is already delivering transformational business value across virtually every industry and business operating model. As companies race to integrate AI into their enterprise environment, AI is changing how they operate. Over the next few years, for example, enterprise investment levels in AI will begin to exceed information technology (IT) spend, and new executive roles with dedicated AI teams will emerge.

Insight

April 2022

Post-Merger Integration (PMI) in Life Sciences: Levers for Your Success

Ebook

April 2022

Launching in a New Therapeutic Area

Insight

May 2024

Preparing for the Next Decentralized Clinical Trial Quantum Leap

The clinical trial landscape is transforming and pivoting away from its reliance on data collection within the confines of traditional research facilities.